Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
August 14, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines
August 14, 2024 01:00 ET
|
Nykode Therapeutics ASA
OSLO, Norway, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...
Medical Endoscope Image Processor Market to Reach $2.9 Billion, Globally, by 2033 at 6.8% CAGR: Allied Market Research
August 13, 2024 20:30 ET
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Medical Endoscope Image Processor Market by Product Type (HD Image Processors, 3D Image...
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024 16:18 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
August 13, 2024 16:00 ET
|
ACELYRIN, INC.
Phase 3 trial of izokibep in hidradenitis suppurativa met primary endpoint of HiSCR75 at 12 weeks Company to prioritize development of lonigutamab; dose confirmation ongoing in Phase 2 trial with...
Four First-Time Moms Welcome 24 Offspring During Leader Dogs for the Blind's Puppy Boom
August 13, 2024 14:44 ET
|
Leader Dogs for the Blind
Rochester Hills, Michigan, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Leader Dogs for the Blind is excited to announce that four first-time Leader Dog Moms have given birth to a total of 24 puppies that are...
Crnic Institute Clinical Trial Shows JAK Inhibitor Improves Multiple Autoimmune Conditions in Patients with Down Syndrome
August 13, 2024 13:48 ET
|
Global Down Syndrome Foundation
Denver, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Global Down Syndrome Foundation (GLOBAL) is proud to support a new study published in eLIFE by researchers from its partner and Affiliate, the Linda...
Prader–Willi Syndrome Market is Expected to Showcase Growth at a CAGR of ~6% by 2034 | DelveInsight
August 13, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Prader–Willi Syndrome Market is Expected to Showcase Growth at a CAGR of ~6% by 2034 | DelveInsight The Prader–Willi syndrome market is...
Chronic Myelomonocytic Leukemia Clinical Trial Pipeline Analysis Demonstrates 22+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
August 13, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Chronic Myelomonocytic Leukemia Clinical Trial Pipeline Analysis Demonstrates 22+ Key Companies at the Horizon Expected to Transform the Treatment...
Immunohematology Market to Reach $3.0 Billion, Globally, by 2033 at 4.6% CAGR: Allied Market Research
August 13, 2024 12:02 ET
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Immunohematology Market by Product (Analyzers and Systems and Reagents), Application...